| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
07-15-2017, 02:03 AM
|
#1 | ||
|
|||
|
Member
|
SoPD article: The Llama-nation of Parkinson's disease, 12 July 2017.
The Llama-nation of Parkinson’s disease | The Science of Parkinson's disease Research overview: Potential therapy for Parkinson's disease through llama antibodies, 4 July 2017. Potential therapy for Parkinson’s disease through llama antibodies - On Biology Research paper: Nanobodies raised against monomeric alpha-synuclein inhibit fibril formation and destabilize toxic oligomeric species, Marija Iljina et al. BMC Biology, 3 July 2017. Nanobodies raised against monomeric ɑ-synuclein inhibit fibril formation and destabilize toxic oligomeric species | BMC Biology | Full Text (this is an open-access research paper) |
||
|
 Reply With Quote
|
| "Thanks for this!" says: | kiwi33 (07-15-2017) |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| Potential therapy for Parkinson's disease through llama antibodies | ALS News & Research | |||
| Emerging EphA4 Nanobodies Aim to Facilitate Axon Regrowth in ALS | ALS News & Research | |||
Potential therapy for PD via llama-derived nanobodies (mini antibodies) against a-syn
Threaded Mode